Sienna Cancer Diagnostics Ltd (ASX: SDX)

Company Profile: Sienna Cancer Diagnostics Ltd (ASX: SDX), established in 2002, is a medical technology company that is based out of Australia and operating across Australia, the United States, and Europe. The services include biotechnology and pharmaceutical R&D, commercialisation, manufacturing operation, and other allied services for clinical diagnostic laboratories. The company specifically operates through its platform that is based on the technology for detecting biomarker telomerase, which is present in almost all kind of epithelial cancers.